Literature DB >> 33904047

Low-Dose Computed Tomographic Screening for Lung Cancer: Time to Implement or Unresolved Questions?

Aakash Desai1, Vinay Prasad2,3.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 33904047      PMCID： PMC8481428          DOI： 10.1007/s11606-021-06806-5

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN： 0884-8734            Impact factor:   6.473


× No keyword cloud information.
  9 in total

1.  Interpreting the Effectiveness of Cancer Screening From National Population Statistics: Is It Sound Practice?

Authors:  Joaquin Chapa; Alyson Haslam; Vinay Prasad
Journal:  Mayo Clin Proc       Date:  2019-06       Impact factor: 7.616

2.  Mortality, survival and incidence rates in the ITALUNG randomised lung cancer screening trial.

Authors:  Eugenio Paci; Donella Puliti; Andrea Lopes Pegna; Laura Carrozzi; Giulia Picozzi; Fabio Falaschi; Francesco Pistelli; Ferruccio Aquilini; Cristina Ocello; Marco Zappa; Francesca M Carozzi; Mario Mascalchi
Journal:  Thorax       Date:  2017-04-04       Impact factor: 9.139

3.  Comparison of Observed Harms and Expected Mortality Benefit for Persons in the Veterans Health Affairs Lung Cancer Screening Demonstration Project.

Authors:  Tanner J Caverly; Angela Fagerlin; Renda Soylemez Wiener; Christopher G Slatore; Nichole T Tanner; Shira Yun; Rodney Hayward
Journal:  JAMA Intern Med       Date:  2018-03-01       Impact factor: 21.873

4.  Lung cancer mortality reduction by LDCT screening-Results from the randomized German LUSI trial.

Authors:  Nikolaus Becker; Erna Motsch; Anke Trotter; Claus P Heussel; Hendrik Dienemann; Philipp A Schnabel; Hans-Ulrich Kauczor; Sandra González Maldonado; Anthony B Miller; Rudolf Kaaks; Stefan Delorme
Journal:  Int J Cancer       Date:  2019-06-20       Impact factor: 7.396

5.  Reduced lung-cancer mortality with low-dose computed tomographic screening.

Authors:  Denise R Aberle; Amanda M Adams; Christine D Berg; William C Black; Jonathan D Clapp; Richard M Fagerstrom; Ilana F Gareen; Constantine Gatsonis; Pamela M Marcus; JoRean D Sicks
Journal:  N Engl J Med       Date:  2011-06-29       Impact factor: 91.245

6.  Lung Cancer Incidence and Mortality with Extended Follow-up in the National Lung Screening Trial.

Authors: 
Journal:  J Thorac Oncol       Date:  2019-06-28       Impact factor: 15.609

7.  Long-Term Follow-up Results of the DANTE Trial, a Randomized Study of Lung Cancer Screening with Spiral Computed Tomography.

Authors:  Maurizio Infante; Silvio Cavuto; Fabio Romano Lutman; Eliseo Passera; Maurizio Chiarenza; Giuseppe Chiesa; Giorgio Brambilla; Enzo Angeli; Giuseppe Aranzulla; Arturo Chiti; Marta Scorsetti; Pierina Navarria; Raffaele Cavina; Michele Ciccarelli; Massimo Roncalli; Anna Destro; Edoardo Bottoni; Emanuele Voulaz; Valentina Errico; Giorgio Ferraroli; Giovanna Finocchiaro; Luca Toschi; Armando Santoro; Marco Alloisio
Journal:  Am J Respir Crit Care Med       Date:  2015-05-15       Impact factor: 21.405

8.  Long-term mortality after screening for colorectal cancer.

Authors:  Aasma Shaukat; Steven J Mongin; Mindy S Geisser; Frank A Lederle; John H Bond; Jack S Mandel; Timothy R Church
Journal:  N Engl J Med       Date:  2013-09-19       Impact factor: 91.245

9.  The Pittsburgh Lung Screening Study (PLuSS): outcomes within 3 years of a first computed tomography scan.

Authors:  David O Wilson; Joel L Weissfeld; Carl R Fuhrman; Stephen N Fisher; Paula Balogh; Rodney J Landreneau; James D Luketich; Jill M Siegfried
Journal:  Am J Respir Crit Care Med       Date:  2008-07-17       Impact factor: 21.405
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.